LEWIN NICHOLAS SHERIDAN
Known title: DirectorCIK: 0001398327
LEWIN NICHOLAS SHERIDAN's purchase track record
How the stock did after each of LEWIN NICHOLAS SHERIDAN's open-market purchases, measured from the purchase date. Several fills within a week count as one purchase.
Purchases measured
4
of 4 since August 15, 2023
Stock higher 6 months later
75%
3 months: 75%
Median 6-month return
+77.7%
3 months: +67.9%
Beat the S&P 500
75%
median +66.4% vs. index
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 8/13/2025 | ESTA | $177K | +64.8% | +89.7% | +7.3% |
| 12/14/2023 | ESTA | $54K | +78.8% | +65.7% | +15.1% |
| 11/20/2023 | ESTA | $110K | +70.9% | +145.4% | +16.7% |
| 8/15/2023 | ESTA | $22K | -54.1% | -33.7% | +11.6% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Transaction History
| ESTA | ▲ Buy | Grant | 389 | $25K | 9/30/2026 | View on chart |
| ESTA | ▲ Buy | Grant | 291 | $25K | 6/30/2026 | View on chart |
| ESTA | ▲ Buy | Grant | 2,354 | $0 | 5/22/2026 | View on chart |
| ESTA | ▲ Buy | Grant | 440 | $25K | 3/31/2026 | View on chart |
| ESTA | ▲ Buy | Grant | 343 | $25K | 12/31/2025 | View on chart |
| ESTA | ▲ Buy | Grant | 609 | $25K | 9/30/2025 | View on chart |
| ESTA | ▲ Buy | Open Market | 2,600 | $98K | 8/14/2025 | View on chart |
| ESTA | ▲ Buy | Open Market | 2,300 | $79K | 8/13/2025 | View on chart |
| ESTA | ▲ Buy | Grant | 585 | $25K | 6/30/2025 | View on chart |
| ESTA | ▲ Buy | Grant | 3,413 | $0 | 5/23/2025 | View on chart |
| ESTA | ▲ Buy | Grant | 612 | $25K | 3/31/2025 | View on chart |
| ESTA | ▲ Buy | Grant | 542 | $25K | 12/31/2024 | View on chart |
| ESTA | ▲ Buy | Grant | 577 | $25K | 9/30/2024 | View on chart |
| ESTA | ▲ Buy | Grant | 550 | $25K | 6/30/2024 | View on chart |
| ESTA | ▲ Buy | Grant | 2,334 | $0 | 5/24/2024 | View on chart |
| ESTA | ▲ Buy | Grant | 491 | $25K | 3/31/2024 | View on chart |
| ESTA | ▲ Buy | Grant | 1,931 | $50K | 12/31/2023 | View on chart |
| ESTA | ▲ Buy | Open Market | 231 | $6K | 12/14/2023 | View on chart |
| ESTA | ▲ Buy | Open Market | 1,769 | $48K | 12/14/2023 | View on chart |
| ESTA | ▲ Buy | Open Market | 5,000 | $110K | 11/20/2023 | View on chart |
| ESTA | ▲ Buy | Option Exercise | 250,000 | $4.5M | 11/13/2023 | View on chart |
| ESTA | ▲ Buy | Open Market | 400 | $22K | 8/15/2023 | View on chart |
| ESTA | ▲ Buy | Grant | 27,756 | $0 | 5/28/2023 | View on chart |
| ESTA | ▲ Buy | Grant | 2,324 | $0 | 5/24/2023 | View on chart |
| ESTA | ▲ Buy | Grant | 2,345 | $0 | 6/17/2022 | View on chart |
| ESTA | ▲ Buy | Open Market | 45 | $986 | 5/23/2019 | View on chart |
| ESTA | ▲ Buy | Open Market | 112 | $3K | 5/17/2019 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 11, 2026
ESTA Receives FDA Approval for New Motiva Implant Sizes
Establishment Labs Holdings received FDA clearance for additional sizes of its Motiva implants, expanding its product lineup. The company also reported its Q2 2026 financial results. This regulatory approval is a key development for the medical device maker, potentially broadening its market reach.
ESTA Receives FDA Approval for New Motiva Implant Sizes. Establishment Labs Holdings received FDA clearance for additional sizes of its Motiva implants, expanding its product lineup. The company also reported its Q2 2026 financial results. This regulatory approval is a key development for the medical device maker, potentially broadening its market reach.